Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT
J Clin Invest. 1993 92 (6): 2569-76

PMID: 7504687 · PMCID: PMC288452 · DOI:10.1172/JCI116871

TGF-beta effects on angiogenesis, stroma formation, and immune function suggest its possible involvement in tumor progression. This hypothesis was tested using the 2G7 IgG2b, which neutralizes TGF-beta 1, -beta 2, and -beta 3, and the MDA-231 human breast cancer cell line. Inoculation of these cells in athymic mice decreases mouse spleen natural killer (NK) cell activity. Intraperitoneal injections of 2G7 starting 1 d after intraperitoneal inoculation of tumor cells suppressed intraabdominal tumor and lung metastases, whereas the nonneutralizing anti-TGF-beta 12H5 IgG2a had no effect. 2G7 transiently inhibited growth of established MDA-231 subcutaneous tumors. Histologically, both 2G7-treated and control tumors were identical. Intraperitoneal administration of 2G7 resulted in a marked increase in mouse spleen NK cell activity. 2G7 did not inhibit MDA-231 primary tumor or metastases formation, nor did it stimulate NK cell-mediated cytotoxicity in beige NK-deficient nude mice. Finally, serum-free conditioned medium from MDA-231 cells inhibited the NK cell activity of human blood lymphocytes. This inhibition was blocked by the neutralizing anti-TGF-beta 2G7 antibody but not by a nonspecific IgG2. These data support a possible role for tumor cell TGF-beta in the progression of mammary carcinomas by suppressing host immune surveillance.

MeSH Terms (22)

Animals Antibodies Breast Neoplasms Cell Division Collagen Cytotoxicity, Immunologic Factor VIII Female Humans Immunoglobulin G Killer Cells, Natural Lung Neoplasms Mice Mice, Nude Neoplasm Metastasis Neoplasm Transplantation Neovascularization, Pathologic Recombinant Proteins Spleen Transforming Growth Factor beta Transplantation, Heterologous Tumor Cells, Cultured

Connections (1)

This publication is referenced by other Labnodes entities: